ALB and cancer: With a composite assessment of ANC, ALC, and albumin values taken at a visit prior to COVID-19 pandemic, we noted that about 60–70% patients had all normal labs, and no difference was found among different groups, or between groups A + B vs. C + D. These results suggest that not all patients with cancer and/or on treatment are rendered a status of severe immunosuppression to the point of being unable to fight the coronavirus.